Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2007 2
2008 1
2012 3
2013 6
2014 5
2015 3
2016 1
2017 2
2018 4
2020 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean neely puri (5 results)?
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.
Racherla KS, Dovalovsky K, Patel M, Harper E, Barnard J, Nasifuzzaman SM, Smith M, Sikand R, Drinka E, Puri N. Racherla KS, et al. Among authors: puri n. Cancers (Basel). 2023 Jul 1;15(13):3461. doi: 10.3390/cancers15133461. Cancers (Basel). 2023. PMID: 37444572 Free PMC article.
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies.
Rager T, Eckburg A, Patel M, Qiu R, Gantiwala S, Dovalovsky K, Fan K, Lam K, Roesler C, Rastogi A, Gautam S, Dube N, Morgan B, Nasifuzzaman SM, Ramaswami D, Gnanasekar V, Smith J, Merchant A, Puri N. Rager T, et al. Among authors: puri n. Cancers (Basel). 2022 Aug 3;14(15):3779. doi: 10.3390/cancers14153779. Cancers (Basel). 2022. PMID: 35954441 Free PMC article. Review.
Resistance to Molecularly Targeted Therapies in Melanoma.
Patel M, Eckburg A, Gantiwala S, Hart Z, Dein J, Lam K, Puri N. Patel M, et al. Among authors: puri n. Cancers (Basel). 2021 Mar 5;13(5):1115. doi: 10.3390/cancers13051115. Cancers (Basel). 2021. PMID: 33807778 Free PMC article. Review.
EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer.
Crees ZD, Shearrow C, Lin L, Girard J, Arasi K, Bhoraskar A, Berei J, Eckburg A, Anderson AD, Garcia C, Munger A, Palani S, Smith TJ, Sreenivassappa SB, Vitali C, David O, Puri N. Crees ZD, et al. Among authors: puri n. Ther Adv Med Oncol. 2020 Sep 14;12:1758835920953731. doi: 10.1177/1758835920953731. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32973931 Free PMC article.
Potential Telomere-Related Pharmacological Targets.
Berei J, Eckburg A, Miliavski E, Anderson AD, Miller RJ, Dein J, Giuffre AM, Tang D, Deb S, Racherla KS, Patel M, Vela MS, Puri N. Berei J, et al. Among authors: puri n. Curr Top Med Chem. 2020;20(6):458-484. doi: 10.2174/1568026620666200109114339. Curr Top Med Chem. 2020. PMID: 31916516 Review.
Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Schrank Z, Khan N, Osude C, Singh S, Miller RJ, Merrick C, Mabel A, Kuckovic A, Puri N. Schrank Z, et al. Among authors: puri n. Molecules. 2018 Sep 5;23(9):2267. doi: 10.3390/molecules23092267. Molecules. 2018. PMID: 30189661 Free PMC article. Review.
Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC.
Iderzorig T, Kellen J, Osude C, Singh S, Woodman JA, Garcia C, Puri N. Iderzorig T, et al. Among authors: puri n. Biochem Biophys Res Commun. 2018 Feb 5;496(2):770-777. doi: 10.1016/j.bbrc.2018.01.069. Epub 2018 Jan 11. Biochem Biophys Res Commun. 2018. PMID: 29337056 Free PMC article.
33 results